A Retrospective Cohort Study of the 2018 Angiotensin Receptor Blocker Recalls and Subsequent Drug Shortages in Patients With Hypertension.
Joshua W DevineMina TadrousInmaculada HernandezKatherine Callaway KimScott D RothenbergerNandita MukhopadhyayWalid F GelladKatie J SudaPublished in: Journal of the American Heart Association (2023)
The valsartan recall and shortage affected hypertensive patients. Local- and national-level systems need to be enhanced to protect patients from drug shortages by providing safe and reliable medication alternatives.
Keyphrases
- quality improvement
- blood pressure
- hypertensive patients
- end stage renal disease
- newly diagnosed
- adverse drug
- chronic kidney disease
- healthcare
- angiotensin converting enzyme
- peritoneal dialysis
- prognostic factors
- angiotensin ii
- emergency department
- patient reported outcomes
- electronic health record
- arterial hypertension